UNA Stock Analysis: Unilever | AS
Household & Personal Products | AS, Netherlands | Market Cap: 119.463m EUR | 12M Return: 0.9% | GB00BVZK7T90 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 50.8M
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Unilever PLC is a global fast-moving consumer goods (FMCG) company headquartered in London, with operations spanning Asia Pacific, Africa, the Americas, and Europe. Founded in 1860, the company operates through four core segments: Beauty & Wellbeing, Personal Care, Home Care, and Foods, covering everyday household and personal use categories.
The Business model relies on a portfolio of well-established consumer brands, with a strong emphasis on personal care and household products. Personal care and home care are typically higher-margin, recurring-purchase categories, while foods-such as soups, seasonings, and condiments-anchor the portfolio in stable, everyday consumption. Brand loyalty and global distribution scale are central to the companys competitive position in the consumer staples sector.
Unilever markets its products under numerous globally recognized names, including Dove, Knorr, Hellmanns, AXE, Rexona, Sunsilk, TRESemmé, Vaseline, and OMO, among others. The extensive brand portfolio spans mass-market and premium offerings (e.g., Dermalogica, Nutrafol, Paulas Choice), allowing the company to address a broad range of price points and consumer segments worldwide.
- Emerging market demand drives volume growth in Personal Care
- Ice cream spin-off sharpens focus on higher-margin Beauty
- Margin recovery under Schumacher action plan gains traction
| Net Income: 5.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.67 > 1.0 |
| NWC/Revenue: -16.32% < 20% (prev -9.89%; Δ -6.43% < -1%) |
| CFO/TA 0.11 > 3% & CFO 8.49b > Net Income 5.62b |
| Net Debt (27.6b) to EBITDA (10.4b): 2.64 < 3 |
| Current Ratio: 0.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.18b) vs 12m ago -13.05% < -2% |
| Gross Margin: 42.76% > 18% (prev 44.14%; Δ -1.38% > 0.5%) |
| Asset Turnover: 60.13% > 50% (prev 78.65%; Δ -18.52% > 0%) |
| Interest Coverage Ratio: 9.03 > 6 (EBIT TTM 9.28b / Interest Expense TTM 1.03b) |
| A: -0.10 (Total Current Assets 21.4b - Total Current Liabilities 28.9b) / Total Assets 76.9b |
| B: 0.60 (Retained Earnings 45.9b / Total Assets 76.9b) |
| C: 0.12 (EBIT TTM 9.28b / Avg Total Assets 76.5b) |
| D: 0.28 (Book Value of Equity 16.2b / Total Liabilities 58.6b) |
| Altman-Z'' = 2.41 = A |
| DSRI: 1.72 (Receivables 10.2b/7.69b, Revenue 46.0b/59.8b) |
| GMI: 1.03 (GM 44.14% / 42.76%) |
| AQI: 0.99 (AQ_t 0.60 / AQ_t-1 0.60) |
| SGI: 0.77 (Revenue 46.0b / 59.8b) |
| TATA: -0.04 (NI 5.62b - CFO 8.49b) / TA 76.9b) |
| Beneish M = -2.57 (Cap -4..+1) = A |
As of September 14, 2026, the stock is trading at EUR 53.12 with a total of 812,888 shares traded. Over the past week, the price has changed by -4.25%, over one month by -1.59%, over three months by +6.20% and over the past year by +0.93%.
Current recommended Stop Loss: 52.00 (which is 2.1% or 1.2 ATR below the current price).
Unilever has no consensus analysts rating.
P/E Trailing = 21.7569
P/E Forward = 16.6389
P/S = 2.36
P/B = 7.4014
P/EG = 11.0932
Revenue TTM = 46.0b EUR
EBIT TTM = 9.28b EUR
EBITDA TTM = 10.4b EUR
Long Term Debt = 24.1b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 8.14b EUR (from shortTermDebt, last quarter)
Debt = 33.4b EUR (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 27.6b EUR (calculated: Debt 33.4b - CCE 5.87b)
Enterprise Value = 147b EUR (119b + Debt 33.4b - CCE 5.87b)
Interest Coverage Ratio = 9.03 (Ebit TTM 9.28b / Interest Expense TTM 1.03b)
EV/FCF = 20.38x (Enterprise Value 147b / FCF TTM 7.22b)
FCF Yield = 4.91% (FCF TTM 7.22b / Enterprise Value 147b)
FCF Margin = 15.69% (FCF TTM 7.22b / Revenue TTM 46.0b)
Net Margin = 12.22% (Net Income TTM 5.62b / Revenue TTM 46.0b)
Gross Margin = 42.76% ((Revenue TTM 46.0b - Cost of Revenue TTM 26.3b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.91 (Enterprise Value 147b / Total Assets 76.9b)
Interest Expense / Debt = 3.07% (Interest Expense 1.03b / Debt 33.4b)
Taxrate = 30.55% (2.53b / 8.29b)
NOPAT = 6.44b (EBIT 9.28b * (1 - 30.55%))
Current Ratio = 0.74 (Total Current Assets 21.4b / Total Current Liabilities 28.9b)
Debt / Equity = 2.06 (Debt 33.4b / totalStockholderEquity, last quarter 16.2b)
Debt / EBITDA = 2.64 (Net Debt 27.6b / EBITDA 10.4b)
Debt / FCF = 3.82 (Net Debt 27.6b / FCF TTM 7.22b)
Total Stockholder Equity = 17.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.35% (Net Income 5.62b / Total Assets 76.9b)
RoE = 32.32% (Net Income TTM 5.62b / Total Stockholder Equity 17.4b)
RoCE = 22.37% (EBIT 9.28b / Capital Employed (Equity 17.4b + L.T.Debt 24.1b))
RoIC = 11.96% (NOPAT 6.44b / Invested Capital 53.9b)
WACC = 4.11% (E(119b)/V(153b) * Re(4.66%) + D(33.4b)/V(153b) * Rd(3.07%) * (1-Tc(0.31)))
Discount Rate = 4.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -79.38 | Cagr: -6.72%
[DCF] Terminal Value 76.55% ; FCFF base≈6.98b ; Y1≈7.53b ; Y5≈9.21b
[DCF] Fair Price = 52.73 (EV 141b - Net Debt 27.6b = Equity 114b / Shares 2.15b; r=8.35% [WACC [floored]]; 5y FCF grow 9.00% → 2.50% )
EPS Correlation: -45.16 | EPS CAGR: -10.09% | SUE: 0.0 | # QB: 0
Revenue Correlation: -10.95 | Revenue CAGR: -1.71% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=3.16 | Chg30d=-1.43% | Revisions=+0% | GrowthEPS=+2.6% | GrowthRev=+2.3%
EPS next Year (2027-12-31): EPS=3.42 | Chg30d=+0.20% | Revisions=+22% | GrowthEPS=+8.2% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +13% (up=7, down=5)